Martin Cannon, PhD

Martin J Cannon, PhD, is Professor of Microbiology and Immunology at the University of Arkansas for Medical Sciences (UAMS). He received his PhD in immunology from the University of London, and pursued postdoctoral research at the National Institute for Medical Research, London, and the Scripps Research Institute, La Jolla before moving to UAMS. Dr. Cannon’s research focuses on novel strategies for dendritic cell (DC) vaccination against ovarian cancer, including recent clinical studies on maintenance Th17-inducing DC vaccination, conducted in partnership with the Mayo Clinic SPORE for ovarian cancer. This timely award from the OCRA will support the development of an integrated and multi-faceted program to target myeloid cell-mediated immune suppression in the ovarian tumor microenvironment, with the goal of enhancing responses to immunotherapy, including DC vaccination. Dr. Cannon has published extensively in the field of ovarian cancer research, and his work has been supported by the Department of Defense Ovarian Cancer Research Program, the Rivkin Center and the National Institutes of Health. Dr. Cannon is a current member of the NIH Immuno-Oncology Research Special Emphasis Panel, and has served as Chair for DOD review panels in breast, prostate and ovarian cancer.